Even though most viruses cause infection directly through mucosal cells, the vast majority of vaccines are administered intramuscularly in a cellular mismatch that doesn't always produce optimum immunity.
Inspired by a parasitic worm that digs its sharp teeth into its host's intestines, Johns Hopkins researchers have designed tiny, star-shaped microdevices that can latch onto intestinal mucosa and release drugs into the body.
Nov 3, 2020
0
292
An experimental treatment for eczema that aims to modify the skin microbiome safely reduced disease severity and increased quality of life for children as young as 3 years of age, a National Institutes of Health study has ...
Sep 9, 2020
0
870
If you can't stand broccoli, celery or kale, you may be a supertaster, and it just might protect you from COVID-19.
May 25, 2021
2
46
COVID-19 may be linked to a rise in bacterial brain infections in children, a new study suggests.
Aug 5, 2022
0
379
A deadly bacteria that can be picked up by a simple sniff can travel to the brain and spinal cord in just 24 hours, a new Griffith University and Bond University study has found.
Jul 8, 2016
2
182
Topical treatment with live Roseomonas mucosa—a bacterium naturally present on the skin—was safe for adults and children with atopic dermatitis (eczema) and was associated with reduced disease severity, according to initial ...
May 3, 2018
0
532
Scientists have shed new light on early events in the battle between COVID-19 and the immune system in the nose, a key entry point for the virus.
Dec 7, 2021
0
267
The coronavirus SARS-CoV-2 is known to infect cells via the receptor ACE2. An international research team under German-Finnish coordination has now identified neuropilin-1 as a factor that can facilitate SARS-CoV-2 entry ...
Oct 20, 2020
0
237
The gastric bacterium H. pylori colonizes the stomachs of around half the human population and can lead to the development of gastric cancer. It is usually acquired in childhood and persists life-long, despite a strong inflammatory ...
Mar 13, 2018
0
416
